Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2003
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002042454A3 Gene involved in schizophrenia
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002036613A3 Regulation of human patched-like protein
03/13/2003WO2002033056A3 Regulation of human serine-threonine protein kinase
03/13/2003WO2002030465A3 Compositions that inhibit proliferation of cancer cells
03/13/2003WO2002026984A3 Potassium channel interactors and uses therefor
03/13/2003WO2002024233A3 Control of nk cell function and survival by modulation of ship activity
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016551A3 Trance regulation of chondrocyte differentiation
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002014487A3 Adeno-associated virus-mediated delivery of angiogenic factors
03/13/2003WO2002008429A3 Vdup1 promoter and methods of use thereof
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002000242A8 Human papilloma virus treatment
03/13/2003WO2001096598A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003WO2001060413A3 Recombinant vector expressing a beta2-adrenergic receptor and use in treating airway and vascular diseases
03/13/2003US20030051270 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
03/13/2003US20030051259 Packaging cells
03/13/2003US20030050470 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050456 Nucleotide sequences coding polypeptide for use in the treatment of brain and psychological disorders
03/13/2003US20030050454 Oligonucleotide sfor use in the treatment of cancer and viral diseases
03/13/2003US20030050443 Prostate specific secreted protein
03/13/2003US20030050442 62 human secreted proteins
03/13/2003US20030050273 Administering recombinant adeno-associated virus virions with a polynucleotide encoding a glial cell line-derived neutrotrophic factor polypeptide operably linked to expression control
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050271 Infecting the vasculature of an organ or a tissue other than a liver with a vector carrying genetic material of interest for a time under conditions which protect from ischemic damage
03/13/2003US20030050269 Polynucleotides and polypeptides of the erythropoietin gene
03/13/2003US20030050266 Anti-tumor effects of prostate carcinoma tumor antigen-1
03/13/2003US20030050265 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding transforming growth factor-beta 2
03/13/2003US20030050262 Inhibition of neurodegeneration
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050258 Methods and compositions for genomic modification
03/13/2003US20030050239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050231 Discovery of new human colon-associated polynucleotides, the polypeptides encoded by them, and antibodies that immuno-specifically bind these polypeptides; diagnosis/medical; anticarcinogenic, -metastasis agents; other colon diorders
03/13/2003US20030049845 Viral envelope protein for use as tools gene therapy
03/13/2003US20030049843 Gene delivery vectors with cell type specificity for mesenchymal stem cells
03/13/2003US20030049842 Nucleotide sequences coding polypeptide for use in gene therapy and treatment of viral diseases
03/13/2003US20030049837 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells
03/13/2003US20030049829 Concentration and lysis of adenovirus-infected cells in a single unit operation
03/13/2003US20030049823 eNOS mutations useful for gene therapy and therapeutic screening
03/13/2003US20030049787 Polynucleotide coding protein for use in the diagnosis and prevention of infections, heart defects, hypotension, ulcers, hypertension, urogenital, osteoporosis, angina pectoris, asthma, allergies, pain, cancer and nervous system disorders
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049689 Generation of polypeptide for use in the treatment of injuries, infections and cancer; obtain library of peptides, join to generate polypeptide, evaluate activity of polypeptide
03/13/2003US20030049688 Protein fragment complementation assays for the detection of biological or drug interactions
03/13/2003US20030049684 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2003US20030049670 Regulation of human leucine aminopeptidase-like enzyme
03/13/2003US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders
03/13/2003US20030049633 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030049605 Display of viral proteins
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049238 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/13/2003US20030049236 Therapy for bone disorders; transduction, cell differentiation
03/13/2003US20030049234 Discovery, localization, harvest, and propagation of an fgf2 and bdnf-responsive population of neural and neuronal progenitor cells in the adult human forebrain
03/13/2003US20030049233 Culture product; accumulation device containing electroconductive rod; nonconductor handle
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003US20030049206 Administering biocompatible-labeled embryonic stem cells to the patient via intravenous injection, and detecting said stem cells to identify tumors in the patient where said stem cells have accumulated
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2459728A1 Late gestation lung genes, fragments and uses thereof
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
03/13/2003CA2457419A1 Sirna knockout assay method and constructs
03/12/2003EP1291434A2 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
03/12/2003EP1291429A1 Novel enzyme gene and its expression product
03/12/2003EP1291424A1 Gasc1 gene
03/12/2003EP1291422A2 Human nucleic acid from ovarian tumor tissue
03/12/2003EP1291419A1 Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
03/12/2003EP1290449A1 Use of the g protein coupled receptor gpr3 to identify apetite control agents
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290214A2 Inhibiting retroviral integration by targeting the atm pathway
03/12/2003EP1290206A2 Recombinant aav vectors for gene therapy of obesity
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290198A2 Vectors for dna delivery
03/12/2003EP1290186A2 Regulation of a human transketolase-like enzyme
03/12/2003EP1290174A2 G-protein coupled receptor org3.
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290166A1 Mutation in the beta 2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
03/12/2003EP1290165A2 Heteromultimeric ion channel receptor and uses thereof
03/12/2003EP1290161A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease
03/12/2003EP1290028A2 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 870